company background image
SQID.F logo

SQI Diagnostics OTCPK:SQID.F Stock Report

Last Price

US$0.015

Market Cap

US$4.5m

7D

0%

1Y

-82.5%

Updated

11 Sep, 2023

Data

Company Financials

SQID.F Stock Overview

SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide.

SQID.F fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

SQI Diagnostics Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SQI Diagnostics
Historical stock prices
Current Share PriceCA$0.015
52 Week HighCA$0.12
52 Week LowCA$0.0093
Beta0.075
1 Month Change0%
3 Month Change14.62%
1 Year Change-82.47%
3 Year Change-91.98%
5 Year Change-84.81%
Change since IPO-98.53%

Recent News & Updates

Recent updates

Shareholder Returns

SQID.FUS Medical EquipmentUS Market
7D0%-0.2%1.3%
1Y-82.5%10.6%29.8%

Return vs Industry: SQID.F underperformed the US Medical Equipment industry which returned -1.8% over the past year.

Return vs Market: SQID.F underperformed the US Market which returned 15.2% over the past year.

Price Volatility

Is SQID.F's price volatile compared to industry and market?
SQID.F volatility
SQID.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.8%
Market Average Movement6.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: SQID.F's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine SQID.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1999n/aAndrew Morrishttps://www.sqidiagnostics.com

SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow.

SQI Diagnostics Inc. Fundamentals Summary

How do SQI Diagnostics's earnings and revenue compare to its market cap?
SQID.F fundamental statistics
Market capUS$4.48m
Earnings (TTM)-US$14.03m
Revenue (TTM)US$2.23m

2.0x

P/S Ratio

-0.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SQID.F income statement (TTM)
RevenueCA$3.05m
Cost of RevenueCA$3.19m
Gross Profit-CA$140.00k
Other ExpensesCA$19.00m
Earnings-CA$19.14m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.047
Gross Margin-4.60%
Net Profit Margin-628.51%
Debt/Equity Ratio-103.3%

How did SQID.F perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.